Literature DB >> 16162012

Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation.

Peter H J Keizers1, Chris de Graaf, Frans J J de Kanter, Chris Oostenbrink, K Anton Feenstra, Jan N M Commandeur, Nico P E Vermeulen.   

Abstract

A series of 3,4-methylenedioxy-N-alkylamphetamines (MDAAs) were automatically docked and subjected to molecular dynamics (MD) simulations in a cytochrome P450 2D6 (CYP2D6) protein model. The predicted substrate binding orientations, sites of oxidation, and relative reactivities were compared to the experimental data of wild-type and Phe120Ala mutant CYP2D6. Automated docking results were not sufficient to accurately rationalize experimental binding orientations of 3,4-methylenedioxy-N-methylamphetamine (MDMA) in the two enzymes as measured with spin lattice relaxation NMR. Nevertheless, the docking results could be used as starting structures for MD simulations. Predicted binding orientations of MDMA and sites of oxidation of the MDAAs derived from MD simulations matched well with the experimental data. It appeared the experimental results were best described in MD simulations considering the nitrogen atoms of the MDAAs in neutral form. Differences in regioselectivity and stereoselectivity in the oxidative metabolism of the MDAAs by the Phe120Ala mutant CYP2D6 were correctly predicted, and the effects of the Phe120Ala mutation could be rationalized as well.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162012     DOI: 10.1021/jm050338+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivators.

Authors:  Mara Livezey; Leslie D Nagy; Laura E Diffenderfer; Evan J Arthur; David J Hsi; Jeffrey M Holton; Laura Lowe Furge
Journal:  Drug Metab Lett       Date:  2012-03

Review 2.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

3.  Ligand-Based Site of Metabolism Prediction for Cytochrome P450 2D6.

Authors:  Patrik Rydberg; Lars Olsen
Journal:  ACS Med Chem Lett       Date:  2011-11-07       Impact factor: 4.345

4.  Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.

Authors:  Agata M Wasik; Michael N Gandy; Matthew McIldowie; Michelle J Holder; Anita Chamba; Anita Challa; Katie D Lewis; Stephen P Young; Dagmar Scheel-Toellner; Martin J Dyer; Nicholas M Barnes; Matthew J Piggott; John Gordon
Journal:  Invest New Drugs       Date:  2011-08-18       Impact factor: 3.850

5.  CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712.

Authors:  Sarah M Glass; Cydney M Martell; Alexandria K Oswalt; Victoria Osorio-Vasquez; Christi Cho; Michael J Hicks; Jacqueline M Mills; Rina Fujiwara; Michael J Glista; Sharat S Kamath; Laura Lowe Furge
Journal:  Drug Metab Dispos       Date:  2018-05-21       Impact factor: 3.922

6.  Binding of 7-methoxy-4-(aminomethyl)-coumarin to wild-type and W128F mutant cytochrome P450 2D6 studied by time-resolved fluorescence spectroscopy.

Authors:  Aike Stortelder; Peter H J Keizers; Chris Oostenbrink; Chris De Graaf; Petra De Kruijf; Nico P E Vermeulen; Cees Gooijer; Jan N M Commandeur; Gert Van der Zwan
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

Review 7.  Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.

Authors:  Sean C Gay; Arthur G Roberts; James R Halpert
Journal:  Future Med Chem       Date:  2010-09       Impact factor: 3.808

8.  Free energies of binding of R- and S-propranolol to wild-type and F483A mutant cytochrome P450 2D6 from molecular dynamics simulations.

Authors:  Chris de Graaf; Chris Oostenbrink; Peter H J Keizers; Barbara M A van Vugt-Lussenburg; Jan N M Commandeur; Nico P E Vermeulen
Journal:  Eur Biophys J       Date:  2007-02-27       Impact factor: 1.733

9.  Substrate specificity and structural characteristics of the novel Rieske nonheme iron aromatic ring-hydroxylating oxygenases NidAB and NidA3B3 from Mycobacterium vanbaalenii PYR-1.

Authors:  Ohgew Kweon; Seong-Jae Kim; James P Freeman; Jaekyeong Song; Songjoon Baek; Carl E Cerniglia
Journal:  mBio       Date:  2010-06-15       Impact factor: 7.867

Review 10.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.